GTF2IRD2B

Across TCGA pan-cancer cohorts, GTF2IRD2B Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GTF2IRD2B data layer compared with 23 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GTF2IRD2B Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated GTF2IRD2B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and LUAD are the cancer types where GTF2IRD2B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.830	.023	14	view →
LUAD	OS	Median	II,III,IV	0.245	0.749	.019	8	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

GTF2IRD2B–UCEC (DFS)

Open the UCEC breakdown →